Some have relabeled it as Pentadecapeptide Aringate or PDA (modifying the acetate to an arginate) and they are prescribing it for subcutaneous administration like that, even though the confusion about its status has led to a vivid oral capsule market for BPC in what appears for being a gray spot https://napoleona320qgv8.wikicommunications.com/user